Ligand validation:5LHV

URA: URACIL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LHV_URA_F_303	98%	1%	0.063	0.988	4.64	4.17	8	5	0	0	100%	0.69
5LHV_URA_A_304	97%	1%	0.066	0.983	4.99	3.04	8	6	0	0	100%	0.53
5LHV_URA_D_303	97%	1%	0.063	0.978	4.94	3.25	8	4	0	0	100%	0.48
5LHV_URA_E_303	97%	1%	0.072	0.984	4.6	3.02	8	4	0	0	100%	0.43
5LHV_URA_C_303	92%	1%	0.082	0.974	4.6	3.08	8	4	0	0	100%	0.47
5LHV_URA_B_304	92%	1%	0.092	0.984	4.74	2.67	8	6	0	0	100%	0.48
5MIW_URA_B_303	100%	3%	0.054	0.996	3.17	2.78	7	3	0	0	100%	1
4OEH_URA_E_301	97%	9%	0.063	0.981	1.61	2.88	1	6	0	0	100%	1
3PNS_URA_I_259	94%	8%	0.079	0.979	1.75	2.79	2	6	3	0	100%	1
4WPL_URA_A_301	100%	37%	0.052	0.995	1.11	1.36	1	1	0	0	100%	1
2RJ3_URA_A_8001	98%	7%	0.062	0.985	1.6	3.18	2	6	0	0	100%	1
1UI0_URA_A_211	97%	19%	0.064	0.981	1.18	2.27	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.